A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

NCT07233291 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis (PsO)

Interventions

DRUG: Oral roflumilast

Sponsor

Ahmed Ibrahim

Collaborators

[object Object]